2022
DOI: 10.2139/ssrn.4212398
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of First-Line Treatments for Recurrent or Metastatic Nasopharyngeal Carcinoma Based on Randomized Controlled Trials

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles